The Department of State is seeking to justify the continued sole-source procurement of RxNT's Electronic Prescribing of Medications, including Controlled Substance (EPMCS) Subscription Services, through a Justification and Approval (J&A) notice. This procurement is essential for the Bureau of Medical Services (MED), which relies on RxNT's unique qualifications and proprietary system that supports over 300 providers globally, ensuring critical 24/7 application support for 20,000 Foreign Service Officers and their families. Transitioning to a different provider would result in significant service disruptions, as RxNT's system offers integrated cross-credentialing and global prescription capabilities that are unmatched by competitors. For further inquiries, interested parties may contact Robin Guillie at guillierl@state.gov or Annie Harlow at harlowal@state.gov.